| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2021 | 0.13 |
—
|
| 2020 | 0.28 |
—
|
| 2019 | ‡‡‡ |
|
| 2018 | 0.00 |
—
|
| 2017 | ‡‡‡ |
|
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash | 6.56 | 6.65 | 6.94 | 5.18 |
| Receivables | 1.59 | 2.86 | 1.39 | 2.00 |
| Inventory | 0.60 | 0.72 | 0.50 | 0.34 |
| Other | 0.70 | 0.31 | 0.41 | 1.73 |
| 9.45 | 10.55 | 9.23 | 9.25 |
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Payables | 2.28 | 3.46 | 2.28 | 2.72 |
| ST’ Debt | 0.22 | 0.15 | 0.08 | 0.17 |
| Other | 0.63 | 0.65 | 0.59 | 0.57 |
| 4.47 | 5.60 | 4.01 | 4.59 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
13.27
|
| ’24 | — | — | — | — |
15.38
|
| ’23 | — | 7.96 | — | — |
17.94
|
| ’22 | — | 6.73 | — | 8.22 |
14.95
|
| ’21 | — | 10.05 | — | 11.33 |
21.39
|
| ’20 | — | 5.72 | — | 7.64 |
13.36
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | (1.41) |
(1.41)
|
| ’24 | — | — | — | 0.78 |
0.78
|
| ’23 | — | — | — | (0.08) |
(0.08)
|
| ’22 | — | — | — | 0.46 |
0.46
|
| ’21 | — | — | — | 2.20 |
2.20
|
| ’20 | — | — | — | (2.03) |
(2.03)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | (1.42) |
(1.42)
|
| ’24 | — | — | — | 0.78 |
0.78
|
| ’23 | — | — | — | (0.08) |
(0.08)
|
| ’22 | — | — | — | 0.45 |
0.45
|
| ’21 | — | — | — | 2.20 |
2.20
|
| ’20 | — | — | — | (0.21) |
(0.21)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’25 | — | — | — | — |
0.02
|
| ’24 | — | — | — | — |
0.10
|
| ’23 | — | (0.03) | — | — |
0.24
|
| ’22 | — | (0.02) | — | 0.07 |
0.05
|
| ’21 | — | 0.07 | — | 0.06 |
0.19
|
| ’20 | — | 0.11 | — | (0.01) |
0.17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.07 | 1.01 | 1.28 | 0.99 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.34 | 1.89 | 1.94 | 1.63 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 24 | 23 | 23 | 24 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.62 | 0.78 | 0.67 | 0.55 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.95 | 17.94 | 15.38 | 13.27 | — | — | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.89% | 21.52% | 28.95% | 27.70% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.56 | 1.70 | 0.92 | 0.19 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.77% | 9.45% | 5.96% | 1.46% | — | — | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.37 | 1.83 | 0.73 | 0.16 | — | — | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.03 | 0.02 | 0.01 | 0.01 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.93 | 2.32 | 1.99 | 1.74 | — | — | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 0.05 | 0.24 | 0.10 | 0.02 | — | — | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.06 | (0.01) | 0.10 | (0.19) | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.06 | (0.01) | 0.10 | (0.19) | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.91 | 2.13 | 2.16 | 2.18 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.73 | 7.73 | 7.72 | 7.60 | — | — | — |
Shares
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.44 | 20.13 | 17.38 | 15.00 | — | — | — |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.29 | 0.36 | 0.31 | 0.27 | — | — | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.70 | 0.76 | 0.64 | 0.56 | — | — | — |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.11 | 0.18 | 0.12 | 0.13 | — | — | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.91 | 2.59 | 1.23 | (15.89) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.46 | (0.08) | 0.78 | (1.41) | — | — | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.01) | 0.00 | 0.00 | (0.01) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.45 | (0.08) | 0.78 | (1.42) | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.98 | 4.95 | 5.22 | 4.66 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.31 | 0.15 | 0.08 | 0.17 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6.25) | (6.49) | (6.85) | (5.01) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.81 | 16.48 | 16.69 | 16.59 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.82% | 8.81% | 3.43% | 0.75% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.88% | (1.56%) | 2.45% | (1.26%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.49% | 11.69% | 4.43% | 0.94% | — | — | — |
ROE
|
Euro Tech Holdings (CLWT), a Nasdaq-listed distributor of water treatment and lab equipment in Greater China, has shown remarkable operational resilience amid China’s industrial slowdowns, trade tensions, and pandemic disruptions, with revenue fluctuating between $13-22 million over nine years but efficiency soaring—revenue per employee up 94% since 2016 despite a 65% headcount cut. Profitability has turned a corner, with EBT margins reaching 9.45% in 2023, ROE peaking at 11.69%, and 2024 delivering positive free cash flow of $0.101 per share from a net cash position exceeding $6.9 million, underscoring a lean, capital-light model with robust working capital.
Yet, the stock trades near multi-year lows—down 70-75% from peaks—decoupling from these gains, with dirt-cheap valuations like a 0.31x P/S, 0.12x EV/sales, and 0.64x P/B, ignored by investors wary of small-cap China risks. While tailwinds from China’s green tech push and stimulus could drive 50%+ re-rating if revenue stabilizes at $15-18 million, downside looms from economic deceleration, delisting pressures, and competition—making this a high-conviction contrarian play only for those prioritizing balance sheet fortitude over cyclical bets.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.